Skip to main content
. Author manuscript; available in PMC: 2016 Jun 21.
Published in final edited form as: Lab Invest. 2015 Nov 2;96(1):81–88. doi: 10.1038/labinvest.2015.125

Figure 4.

Figure 4

Upregulation of TR3 after DHT treatment. (a) Western blot analyses of TR3 protein expression in DHT-treated HaCaT cells. Cells were treated at 0, 10, and 100 nM, respectively. (b) Western blot analyses of TR3 protein expression in DHT-treated primary keratinocytes. Cells were treated at 0, 10, and 100 nM, respectively. Western blot analyses were performed in triplicate at least three times. (c) Transcriptional analysis of TR3 in DHT-treated HaCaT cells. Cells were treated at 0, 10, and 100 nM, respectively. (d) Transcriptional analysis of TR3 in DHT-treated primary keratinocytes. Cells were treated at 0, 10, and 100 nM, respectively. *P<0.05, ***P<0.001.